Desmosterol, a cholesterol-like molecule and direct precursor in the Bloch pathway of cholesterol biosynthesis, is used as an endogenous metabolite to study cholesterol metabolism. It activates LXR and inhibits SREBP, suppressing macrophage inflammasome activation and preventing vascular inflammation and atherosclerosis. Reduced Desmosterol promotes mitochondrial ROS production in macrophages and NLRP3 inflammasome activation. It shows potential for research in inflammation, metabolism, and cardiovascular diseases.
- Home
- Mitochondrial Diseases & Models
- By System Involvement
- Systemic Mitochondrial Disease
- Alpers Disease
- Barth Syndrome
- Carnitine Deficiency
- Creatine Deficiency Syndromes
- Co-Enzyme Q10 Deficience
- Friedreich’s Ataxia
- Kearns-Sayre Syndrome
- Lactic Acidosis
- Leigh Syndrome
- Mitochondrial DNA Depletion Syndrome
- MELAS Syndrome
- Multiple Mitochondrial Dysfunction Syndrome
- Short-Chain Acyl-CoA Dehydrogenase Deficiency
- Thymidine Kinase 2 Deficiency
- Mitochondrial Neurogastrointestinal Encephalopathy
- Organ-specific Mitochondrial Diseases
- Systemic Mitochondrial Disease
- By Etiology
- By System Involvement
- Solutions
- Products
- Mitochondrial Isolation Reagents & Kits
- Mitochondrial Staining Reagents & Kits
- Mitochondrial Disease Diagnostic Reagents & Kits
- Biochemical Inhibitors & Activators
- Mitochondrial Specific Antibodies
- Mitochondrial Recombinant Proteins
- Mitochondria Related Peptides
- Natural Products Targeting Mitochondria
- Resource
- Company